HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bing Dai Selected Research

Therapeutics

2/2024A novel role for the ROS-ATM-Chk2 axis mediated metabolic and cell cycle reprogramming in the M1 macrophage polarization.
1/2024Comparison between high-flow nasal cannula and conventional oxygen therapy in COVID-19 patients: a systematic review and meta-analysis.
11/2023Combination of eriocalyxin B and homoharringtonine exerts synergistic anti-tumor effects against t(8;21) AML.
7/2023Aerosol therapy in adult critically ill patients: a consensus statement regarding aerosol administration strategies during various modes of respiratory support.
1/2023Cyclophosphamide induced early remission and was superior to rituximab in idiopathic membranous nephropathy patients with high anti-PLA2R antibody levels.
1/2022Effectiveness of the use of a high-flow nasal cannula to treat COVID-19 patients and risk factors for failure: a meta-analysis.
1/2021The efficacy and tolerance of prone positioning in non-intubation patients with acute hypoxemic respiratory failure and ARDS: a meta-analysis.
6/2020Should the High-flow Nasal Oxygen Therapy be used or Avoided in COVID-19?
1/2020Inhaled antibiotics therapy for stable non-cystic fibrosis bronchiectasis: a meta-analysis.
1/2012Identification and expansion of cancer stem cells in tumor tissues and peripheral blood derived from gastric adenocarcinoma patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bing Dai Research Topics

Disease

13Autosomal Dominant Polycystic Kidney (ADPKD)
01/2017 - 06/2004
10Neoplasms (Cancer)
03/2024 - 06/2009
8Inflammation (Inflammations)
02/2024 - 01/2012
6COVID-19
01/2024 - 06/2020
6Asthma (Bronchial Asthma)
12/2023 - 02/2018
6Fibrosis (Cirrhosis)
01/2022 - 07/2010
6Cysts
01/2011 - 11/2005
5Pneumonia (Pneumonitis)
02/2024 - 10/2013
5Chronic Renal Insufficiency
10/2018 - 01/2012
4Acute Kidney Injury (Acute Renal Failure)
01/2021 - 01/2012
3Atherosclerosis
01/2024 - 06/2009
3Respiratory Insufficiency (Respiratory Failure)
01/2024 - 01/2021
3Chronic Obstructive Pulmonary Disease (COPD)
01/2021 - 01/2018
3Kidney Diseases (Kidney Disease)
12/2015 - 07/2010
2Postmenopausal Osteoporosis
05/2024 - 01/2023
2Hypersensitivity (Allergy)
01/2024 - 01/2017
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2023 - 11/2021
2Nephrotic Syndrome (Syndrome, Nephrotic)
09/2023 - 04/2021
2Critical Illness (Critically Ill)
07/2023 - 01/2021
2Hemorrhage
01/2023 - 01/2017
2Hypoxia (Hypoxemia)
01/2022 - 11/2021
2Chronic Kidney Failure (Chronic Renal Failure)
01/2022 - 10/2014
2Sepsis (Septicemia)
06/2020 - 01/2020
2Disease Progression
01/2020 - 05/2006
2Hypertrophy
01/2020 - 01/2019
2Polycystic Kidney Diseases (Polycystic Kidney Disease)
10/2018 - 07/2010
2Cardiovascular Diseases (Cardiovascular Disease)
10/2018 - 01/2017
2Type 2 Diabetes Mellitus (MODY)
01/2017 - 11/2016
2Proteinuria
01/2017 - 06/2014
1Ataxia Telangiectasia (Louis Bar Syndrome)
02/2024
1Hyperlipidemias (Hyperlipidemia)
01/2024
1Thrombosis (Thrombus)
01/2024
1Wounds and Injuries (Trauma)
01/2024
1Fever (Fevers)
01/2024
1Embolism (Embolus)
01/2024
1Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
01/2024
1Dyspnea (Shortness of Breath)
01/2024
1Chest Pain (Chest Pains)
01/2024
1Hyperplasia
12/2023
1Airway Remodeling
12/2023
1Hepatocellular Carcinoma (Hepatoma)
06/2023

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
01/2022 - 11/2005
6Oxygen (Dioxygen)IBA
01/2024 - 09/2010
5Fibroblast Growth Factor-23IBA
01/2022 - 01/2012
4Biomarkers (Surrogate Marker)IBA
01/2022 - 12/2013
3Anti-Bacterial Agents (Antibiotics)IBA
01/2024 - 07/2010
3Rituximab (Mabthera)FDA Link
09/2023 - 04/2021
3Messenger RNA (mRNA)IBA
01/2018 - 11/2005
3Rosiglitazone (Avandia)FDA Link
01/2011 - 06/2010
3PPAR gammaIBA
07/2010 - 06/2009
2LipopolysaccharidesIBA
02/2024 - 11/2022
2LipidsIBA
01/2024 - 01/2020
2oxidized low density lipoproteinIBA
01/2024 - 09/2017
2Interleukin-6 (Interleukin 6)IBA
01/2024 - 01/2020
2Glycoproteins (Glycoprotein)IBA
01/2024 - 05/2006
2CollagenIBA
12/2023 - 01/2012
2OvalbuminIBA
12/2023 - 01/2021
2Fibronectins (Fibronectin)IBA
01/2022 - 01/2011
2RNA (Ribonucleic Acid)IBA
11/2021 - 01/2021
2Fibroblast Growth Factor 1 (FGF-1)IBA
01/2021 - 09/2020
2Interleukin-18 (Interleukin 18)IBA
06/2020 - 12/2013
2LigandsIBA
01/2020 - 06/2010
2SmokeIBA
01/2019 - 01/2018
2EucalyptolIBA
01/2019 - 01/2018
2AntioxidantsIBA
01/2017 - 12/2016
2hydroxide ionIBA
12/2013 - 11/2012
2PPAR-gamma AgonistsIBA
07/2010 - 06/2009
13-Hydroxyanthranilic AcidIBA
05/2024
1Circulating MicroRNAIBA
03/2024
1MicroRNAs (MicroRNA)IBA
03/2024
1Phosphotransferases (Kinase)IBA
02/2024
1Reactive Oxygen Species (Oxygen Radicals)IBA
02/2024
1Triglycerides (Triacylglycerol)IBA
01/2024
1Apolipoproteins E (ApoE)IBA
01/2024
1PolyphenolsIBA
01/2024
1CholesterolIBA
01/2024
1gastrodinIBA
01/2024
1fibrin fragment D (D-dimer)IBA
01/2024
1AntibodiesIBA
01/2024
1SolutionsIBA
01/2024
1GlucocorticoidsIBA
01/2024
1Novo-Helisen DepotIBA
01/2024
1nirmatrelvir and ritonavir drug combinationIBA
01/2024
1Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
01/2024
1Sirtuin 2IBA
12/2023
1eriocalyxin BIBA
11/2023
1HomoharringtonineIBA
11/2023
1AerosolsIBA
07/2023
1sintilimabIBA
06/2023

Therapy/Procedure

10Therapeutics
02/2024 - 01/2012
5Renal Dialysis (Hemodialysis)
11/2023 - 10/2018
4Cannula
01/2024 - 01/2022
3Noninvasive Ventilation
07/2023 - 01/2021
2Immunotherapy
01/2024 - 01/2021
2Blood Transfusion (Blood Transfusions)
01/2023 - 01/2017
2Catheters
01/2022 - 01/2019
2Drug Therapy (Chemotherapy)
06/2019 - 02/2018
2Oral Administration
01/2018 - 08/2010
1Continuous Renal Replacement Therapy
11/2023
1Artificial Respiration (Mechanical Ventilation)
07/2023